文献速递头颈外科咽喉与嗓音

口咽癌经口机器人手术或放疗后3年的吞咽困难与生活质量

Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy.
PubMed 文献 · Laryngoscope · 2022-10-14

前瞻性队列研究纳入44例口咽癌患者(31例接受经口机器人手术,13例接受放疗),比较治疗前及治疗后1年与3年的吞咽功能和生活质量。两组的梨状窦潴留均显著改善;经口机器人手术组的安全评分、吞咽毒性动态影像分级(DIGEST)和效率评分均改善,放疗组仅后两者改善;经口机器人手术组MDADI综合评分改善,但生活质量改善未达临床意义。

要点

  • 两组的梨状窦潴留从1年到3年均显著改善。
  • 经口机器人手术组安全评分、DIGEST和效率评分均改善,放疗组仅DIGEST和效率评分改善。
  • 经口机器人手术组MDADI综合评分改善,但生活质量改善未达临床意义。

核心结论

  • 治疗1年至3年吞咽功能显著改善,尤其在经口机器人手术组,但未反映为生活质量的临床意义改善。

研究设计与样本

  • 前瞻性队列研究,在哥本哈根大学医院开展,纳入治疗前44例口咽癌患者,31例接受经口机器人手术,13例接受放疗。

主要发现

  • 两组的梨状窦潴留FEES评分均显著改善。
  • 经口机器人手术组安全评分、DIGEST评分和效率评分均改善,放疗组仅DIGEST评分和效率评分改善。
  • 经口机器人手术组MDADI综合评分改善,但生活质量改善未达临床意义。

关键数值与推荐

  • 吞咽功能采用FEES和VF评估。
  • 生活质量采用EORTC QLQ-C30、EORTC QLQ-HN35和MDADI评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE(S): To investigate dysphagia and quality of life (QoL) outcomes 3 years after treatment of oropharyngeal cancer with either primary trans oral robotic surgery (TORS) or radiotherapy (RT). METHODS: A prospective cohort study conducted at the Copenhagen University Hospital. Endpoints were objective swallowing function, examined using fiberoptic endoscopic evaluation of swallowing (FEES) and video fluoroscopy (VF). QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30), Head & Neck Module (EORTC QLQ-HN35), and MD Anderson Dysphagia Inventory (MDADI). A comparison was made between 1-, and 3-year results. RESULTS: Forty-four patients were included prior to treatment, 31 treated with TORS and 13 with RT. One-year results for this cohort have previously been published (https://doi.org/10.1080/00016489.2020.1836395). Significant improvement on FEES in retention at the piriform sinus was noted in both groups. Patients treated with TORS had improved safety scores as well as dynamic imaging grade of swallowing toxicity (DIGEST) and efficiency scores, whereas patients treated with RT only had improvements in the latter two. Improvement in QoL scores was only noted for patients treated with TORS in composite MDADI scores. CONCLUSION: We found significant improvements in objective swallowing function from one to 3 years after treatment, particularly in patients treated with TORS. However, these improvements were not reflected as clinically meaningful improvements in QoL. LEVEL OF EVIDENCE: 3, cohort follow-up study Laryngoscope, 133:1893-1898, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Scott SI, Madsen AKØ, Rubek N, et al. Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy. Laryngoscope. 2022. PMID: 36239625. doi:10.1002/lary.30410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。